BACKGROUND: Hepatitis C virus (HCV) core and nonstructural (NS) 3 proteins induce inflammation and immunity through a toll-like receptor (TLR) 2-dependent pathway. Individuals with the R753Q single-nucleotide polymorphism (SNP) in the TLR2 gene have increased the risk of allograft failure after liver transplantation for chronic hepatitis C. METHODS: To test the hypothesis that R753Q SNP impairs TLR2 recognition of HCV proteins, a series of in vitro experiments were performed wherein stable clones of wild-type TLR2-deficient human embryonic kidney (HEK) 293 cells and HEK293 cells transfected with wild-type (HEK293-TLR2) or variant TLR2 genes (HEK293-TLR2-R753Q) were stimulated with HCV core and NS3 proteins. Cellular activation was assessed by nuclear factor-kappa B-driven luciferase activity, cytokine secretion, and gene upregulation. RESULTS: Compared with TLR2-deficient HEK293 cells, HEK293-TLR2 cells had marked nuclear factor-kappa B-driven luciferase activity, had modest to marked upregulation in TLR2 signaling-associated genes, and secreted large quantities of interleukin-8 during exposure to HCV core and NS3 proteins. In contrast, HEK293-TLR2-R753Q cells did not respond to stimulation with HCV and behaved similarly like TLR2-deficient HEK293 cells. CONCLUSION: R753Q SNP impairs TLR2-mediated immune recognition of HCV core and NS3 proteins. This biologic defect may account for the predisposition of patients to develop allograft failure after liver transplantation for chronic hepatitis C.
BACKGROUND:Hepatitis C virus (HCV) core and nonstructural (NS) 3 proteins induce inflammation and immunity through a toll-like receptor (TLR) 2-dependent pathway. Individuals with the R753Q single-nucleotide polymorphism (SNP) in the TLR2 gene have increased the risk of allograft failure after liver transplantation for chronic hepatitis C. METHODS: To test the hypothesis that R753Q SNP impairs TLR2 recognition of HCV proteins, a series of in vitro experiments were performed wherein stable clones of wild-type TLR2-deficient human embryonic kidney (HEK) 293 cells and HEK293 cells transfected with wild-type (HEK293-TLR2) or variant TLR2 genes (HEK293-TLR2-R753Q) were stimulated with HCV core and NS3 proteins. Cellular activation was assessed by nuclear factor-kappa B-driven luciferase activity, cytokine secretion, and gene upregulation. RESULTS: Compared with TLR2-deficientHEK293 cells, HEK293-TLR2 cells had marked nuclear factor-kappa B-driven luciferase activity, had modest to marked upregulation in TLR2 signaling-associated genes, and secreted large quantities of interleukin-8 during exposure to HCV core and NS3 proteins. In contrast, HEK293-TLR2-R753Q cells did not respond to stimulation with HCV and behaved similarly like TLR2-deficientHEK293 cells. CONCLUSION: R753Q SNP impairs TLR2-mediated immune recognition of HCV core and NS3 proteins. This biologic defect may account for the predisposition of patients to develop allograft failure after liver transplantation for chronic hepatitis C.
Authors: N C Arbour; E Lorenz; B C Schutte; J Zabner; J N Kline; M Jones; K Frees; J L Watt; D A Schwartz Journal: Nat Genet Date: 2000-06 Impact factor: 38.330
Authors: R Sreekumar; A Gonzalez-Koch; Y Maor-Kendler; K Batts; L Moreno-Luna; J Poterucha; L Burgart; R Wiesner; W Kremers; C Rosen; M R Charlton Journal: Hepatology Date: 2000-11 Impact factor: 17.425
Authors: E Lien; T J Sellati; A Yoshimura; T H Flo; G Rawadi; R W Finberg; J D Carroll; T Espevik; R R Ingalls; J D Radolf; D T Golenbock Journal: J Biol Chem Date: 1999-11-19 Impact factor: 5.157
Authors: Timothy McCashland; Kymberly Watt; Elizabeth Lyden; Leon Adams; Michael Charlton; Alastair D Smith; Brendan M McGuire; Scott W Biggins; Guy Neff; James R Burton; Hugo Vargas; John Donovan; James Trotter; Thomas Faust Journal: Liver Transpl Date: 2007-09 Impact factor: 5.799
Authors: Raymund R Razonable; Kelly W Burak; Hester van Cruijsen; Robert A Brown; Michael R Charlton; Thomas F Smith; Mark J Espy; Walter Kremers; Jennie A Wilson; Cynthia Groettum; Russell Wiesner; Carlos V Paya Journal: Clin Infect Dis Date: 2002-09-26 Impact factor: 9.079
Authors: Seung H Kang; Rima C Abdel-Massih; Robert A Brown; Ross A Dierkhising; Walter K Kremers; Raymund R Razonable Journal: J Infect Dis Date: 2012-01-04 Impact factor: 5.226
Authors: U Schnetzke; B Spies-Weisshart; O Yomade; M Fischer; T Rachow; K Schrenk; A Glaser; M von Lilienfeld-Toal; A Hochhaus; S Scholl Journal: Genes Immun Date: 2014-11-27 Impact factor: 2.676